ITPD950089A0 - Acido ialuronico e suoi derivati esterei per la preparazione di matri-ci per il rilascio controllato di farmaci - Google Patents
Acido ialuronico e suoi derivati esterei per la preparazione di matri-ci per il rilascio controllato di farmaciInfo
- Publication number
- ITPD950089A0 ITPD950089A0 ITPD950089A ITPD950089A ITPD950089A0 IT PD950089 A0 ITPD950089 A0 IT PD950089A0 IT PD950089 A ITPD950089 A IT PD950089A IT PD950089 A ITPD950089 A IT PD950089A IT PD950089 A0 ITPD950089 A0 IT PD950089A0
- Authority
- IT
- Italy
- Prior art keywords
- matri
- drugs
- preparation
- hyaluronic acid
- controlled release
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95PD000089A IT1281876B1 (it) | 1995-05-10 | 1995-05-10 | Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. |
AU58945/96A AU5894596A (en) | 1995-05-10 | 1996-05-08 | A dicarboxylic acid hemiester or hemiamide with a pharmacolo gically active compound and with hyaluronic acid or with a h yaluronic acid ester, a process for its preparation and a co ntrolled release medicament containing this derivative |
PCT/EP1996/001980 WO1996035721A1 (en) | 1995-05-10 | 1996-05-08 | A dicarboxylic acid hemiester or hemiamide with a pharmacologically active compound and with hyaluronic acid or with a hyaluronic acid ester, a process for its preparation and a controlled release medicament containing this derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95PD000089A IT1281876B1 (it) | 1995-05-10 | 1995-05-10 | Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITPD950089A0 true ITPD950089A0 (it) | 1995-05-10 |
ITPD950089A1 ITPD950089A1 (it) | 1996-11-10 |
IT1281876B1 IT1281876B1 (it) | 1998-03-03 |
Family
ID=11391039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT95PD000089A IT1281876B1 (it) | 1995-05-10 | 1995-05-10 | Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5894596A (it) |
IT (1) | IT1281876B1 (it) |
WO (1) | WO1996035721A1 (it) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6254853B1 (en) * | 1998-05-08 | 2001-07-03 | Vyrex Corporation | Water soluble pro-drugs of propofol |
KR20010025040A (ko) * | 1998-05-20 | 2001-03-26 | 나가야마 오사무 | 관절질환 치료제 및 히알루론산의 결합체 |
ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
WO2005066214A1 (ja) * | 2004-01-07 | 2005-07-21 | Seikagaku Corporation | ヒアルロン酸誘導体及びそれを含む薬剤 |
ITPD20050056A1 (it) | 2005-03-02 | 2006-09-03 | Fidia Farmaceutici | Derivati ammidici del'acido ialuronico in osteoartrosi |
IE20060049A1 (en) * | 2006-01-25 | 2007-08-08 | Eurand Pharmaceuticals Ltd | A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents |
IE20070900A1 (en) * | 2007-12-12 | 2009-06-24 | Eurand Pharmaceuticals Ltd | New anticancer conjugates |
IT1391251B1 (it) * | 2008-10-15 | 2011-12-01 | Innovative Nutrition & Pharma Srl | Composizione per il trattamento delle patologie articolari |
JP5542687B2 (ja) * | 2008-11-05 | 2014-07-09 | 国立大学法人 東京医科歯科大学 | ヒアルロン酸誘導体、およびその医薬組成物 |
ES2665254T3 (es) * | 2011-07-12 | 2018-04-25 | Holy Stone Healthcare Co., Ltd. | Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas |
CN104603156B (zh) * | 2012-09-05 | 2016-10-26 | 中外制药株式会社 | 引入有氨基酸和甾基的透明质酸衍生物 |
WO2015005458A1 (ja) * | 2013-07-10 | 2015-01-15 | 生化学工業株式会社 | グリコサミノグリカン誘導体及びその製造方法 |
US10675354B2 (en) | 2013-07-10 | 2020-06-09 | Seikagaku Corporation | Glycosaminoglycan derivative and method for producing same |
GB2518405A (en) * | 2013-09-20 | 2015-03-25 | Zeiss Carl Meditec Ag | Composition comprising at least one viscoelastic polymer |
SI3226905T1 (sl) | 2014-02-27 | 2022-04-29 | Synartro Ab | Konjugati hialuronana s farmacevtskimi učinkovinami, postopki in sestavki |
JP7641129B2 (ja) | 2020-02-05 | 2025-03-06 | 旭化成株式会社 | ヒアルロン酸誘導体組成物、医薬組成物及びヒアルロン酸誘導体-薬物結合体組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2604930B2 (ja) * | 1990-12-14 | 1997-04-30 | 株式会社ディ・ディ・エス研究所 | ヒアルロン酸およびコンドロイチン誘導体 |
EP0540751A4 (en) * | 1991-05-20 | 1994-10-26 | Eisai Co Ltd | Steroid compound combined with polysaccharide |
JPH0616702A (ja) * | 1992-04-21 | 1994-01-25 | Shiseido Co Ltd | 修飾ヒアルロン酸、その製造方法及びそれを用いた徐放化製剤 |
-
1995
- 1995-05-10 IT IT95PD000089A patent/IT1281876B1/it active IP Right Grant
-
1996
- 1996-05-08 WO PCT/EP1996/001980 patent/WO1996035721A1/en active Application Filing
- 1996-05-08 AU AU58945/96A patent/AU5894596A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ITPD950089A1 (it) | 1996-11-10 |
AU5894596A (en) | 1996-11-29 |
WO1996035721A1 (en) | 1996-11-14 |
IT1281876B1 (it) | 1998-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITPD950089A0 (it) | Acido ialuronico e suoi derivati esterei per la preparazione di matri-ci per il rilascio controllato di farmaci | |
FI944275L (fi) | Menetelmä syklisten estereiden valmistamiseksi hydroksihapoista ja niiden johdannaisista | |
MX9205168A (es) | Derivados de esteres azabiciclicos fusionados y procedimiento para su preparacion. | |
MX9206236A (es) | Composiciones farmaceuticas de liberacion controlada y proceso para su preparacion. | |
ITMI922006A0 (it) | Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preprazione | |
FI945476L (fi) | Hitaasti vapautuvat koostumukset ja menetelmä farmaseuttisten koostumusten valmistamiseksi | |
ITPD920071A0 (it) | Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo | |
FI945776L (fi) | Yhden astian menetelmä 3-kinolonikarboksyylihaapojohdannaisten valmistamiseksi | |
HU9502520D0 (en) | Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives | |
MX9205916A (es) | Derivados de acido ciclohexanoacetico, proceso para su preparacion y composicion farmaceutica que los comprende | |
PT956010E (pt) | Micro-esferas farmaceuticas de acido valproico para administracao oral | |
ITMI962406A0 (it) | Procedimento per la preparazione di derivati cefalosporanici | |
PT801561E (pt) | Composicao e metodos para a entrega transdermica de drogas labeis a acido | |
FI972949A0 (fi) | Lääkemuoto kollagenaasin vapauttamiseksi haavoihin ja sen valmistusmenetelmiä | |
ITPD910160A0 (it) | Esteri di derivati carbossilici di polisaccaridi | |
IT1241128B (it) | Procedimento per la preparazione di derivati chinazolinici | |
PT876367E (pt) | Derivados de esteres do acido trans-apovincaminico utilizados como farmacos | |
ITMI920560A1 (it) | Procedimento per la preparazione di acido iodesossicolico ad elevata purezza per impiego farmaceutico | |
FI973277A0 (fi) | Farmaseuttisia valmisteita TNF:n estämiseksi | |
IT1284090B1 (it) | Procedimento per la preparazione di cefem derivati | |
PL301415A1 (en) | Novel derivatives of phenyloacetic acid, method of obtaining such derivative, pharmaceutical and method of obtaining /2-(2,6-dichloroanilline)phenylo/-acetoxyacetic acid | |
ITPD940069A0 (it) | Derivati viscoelastici di acido ialuronico | |
ITMI950780A0 (it) | Estere chinolonico di derivati dell'acido 3-cefem-4-carbossilico | |
ITMI921125A1 (it) | Procedimento per la preparazione di derivati beta-lattamici alogenati | |
ITMI951297A0 (it) | Processo per la preparazione di derivati dell'acido-metil-2- tiofeneacetico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |